Novel Adeno-associated Virus Vectors Energizing Neuroscience

Novel Adeno-associated Virus Vectors Energizing Neuroscience

RELEASE DATE
15-Jun-2018
REGION
Global
Research Code: D758-00-7E-00-00
SKU: HC03043-GL-TA_22106

$250.00

Special Price $187.50 save 25 %

In stock
SKU
HC03043-GL-TA_22106

$250.00

$187.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This edition of the Genetic Technology TOE provides insights across new gene therapy technologies enabling enhanced management of neurological disorders. The service encompasses the impact and opportunity of gene therapy technologies in the neuroscience industry, while providing an overview of IP and R&D trends in this space. Additionally, this TOE analyzes gene therapy methods and profiles Voyager Therapeutics, US.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Adeno-associated virus gene therapy, AAV vector, gene delivery, biomanufacturing, neuroscience, central nervous system, Tauopathies, Alzheimer’s disease, PSP, FTD, chronic pain, Friedreich’s ataxia, Parkinson’s disease, Huntington’s disease, monogenic ALS

Table of Contents

Recent Advances in Gene Therapy Applied to Neuroscience

  • Gene Therapy: Impact and Opportunity
  • Adeno-associated Virus Gene Therapy
  • Gene Therapy Innovation Scouting
  • Gene Therapy Approaches, Features, and Targeted Areas

Clinical Trial Analysis and Key Contacts

  • Clinical Trial Analysis: Voyager Therapeutics’ Pipeline
  • Key Contacts
Related Research
This edition of the Genetic Technology TOE provides insights across new gene therapy technologies enabling enhanced management of neurological disorders. The service encompasses the impact and opportunity of gene therapy technologies in the neuroscience industry, while providing an overview of IP and R&D trends in this space. Additionally, this TOE analyzes gene therapy methods and profiles Voyager Therapeutics, US. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Adeno-associated virus gene therapy, AAV vector, gene delivery, biomanufacturing, neuroscience, central nervous system, Tauopathies, Alzheimer’s disease, PSP, FTD, chronic pain, Friedreich’s ataxia, Parkinson’s disease, Huntington’s disease, monogenic ALS
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number D758-00-7E-00-00
Is Prebook No
Ti Codes D753,D904,D913,D91A,D91B,D932,D933,D935